Cargando…
Role of circulating tumor DNA in the management of early‐stage lung cancer
Lung cancer is one of the most common cancers and the predominant cause of cancer‐related death in the world. The low accuracy of early detection techniques and high risk of relapse greatly contribute to poor prognosis. An accurate clinical tool that can assist in diagnosis and surveillance is urgen...
Autores principales: | Zhao, Heng, Chen, Ke‐Zhong, Hui, Ben‐Gang, Zhang, Kai, Yang, Fan, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928385/ https://www.ncbi.nlm.nih.gov/pubmed/29528556 http://dx.doi.org/10.1111/1759-7714.12622 |
Ejemplares similares
-
Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
por: Vlataki, Katerina, et al.
Publicado: (2023) -
Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
por: Chen, Ke-Zhong, et al.
Publicado: (2016) -
Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019) -
Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker
por: Lam, Wai Kei Jacky, et al.
Publicado: (2019) -
Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)